Research activity

Here is a list of all the research activity pages:

Generic List

For Investigators

Description
The University of Birmingham Clinical Trials Unit. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial. Multi-centre, international, open label, factorial design, randomized control trial in severe ANCA-associated vasculitis (AAV).

For Investigators

Description
PREDNOS 2 is a national multicentre randomised double blind trial of short course daily prednisolone therapy at the time of upper respiratory tract infection (URTI) in children with relapsing steroid sensitive nephrotic syndrome (SSNS). The aim of the study is to evaluate the effectiveness of a six day course of daily prednisolone therapy at the time of URTI in reducing the development of subsequent nephrotic syndrome relapse in children with relapsing SSNS.

For Investigators

Description
The PRE-EMPT Trial: Preventing Recurrence of Endometriosis by Means of long acting Progestogen Therapy

For Investigators

Description
eGFR-C is a national multicentre prospective longitudinal study investigating the accuracy of different methods of glomerular filtration rate (GFR) estimation run by University of Birmingham Clinical Trials Unit.

For participants

Description
Information for patients on ExACT-Extended anticoagulation treatment for VTE: a randomised trial

For Participants

Description
The PD SURG study is a multi centre clinical trial ran by Birmingham Clinical Trials Unit and sponsored by the University of Birmingham. It's an investigation into the clinical and cost-effectiveness of deep brain stimulation (neurosurgery) in patients with Parkinson's.

For Participants

Description
PD GEN is a DNA databank for patients with Parkinson's, from the large randomised controlled trials PD MED, PD SURG, PD REHAB & PD COMM.

For Participants

Description
PD MED is a large randomised clinical trial investigating the clinical and cost effectiveness of the different classes of drugs in the treatment of patients with Parkinson's disease.
Displaying 41 to 50 of 80
Previous 3 4 5 6 7 Next